Physician versus patient use of AI for diabetes prevention: public perceptions and comfort levels
Frontiers in Digital Health · 27.07.2026 · 8
DOI: 10.3389/fdgth.2026.1879415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Digital Health, online erschienen am 27.07.2026. Verfasst von Gloria Maria Carmona Clavijo und 3 weiteren Autor:innen. Beteiligte Einrichtung: TIERRA - Trust, Innovation & Ethics Research for Responsible AI, Department of Learning Health Science, Michigan Medicine, University of Michigan, An…. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes is a major public health challenge that can often be prevented through lifestyle interventions. Artificial intelligence (AI) is increasingly used for risk prediction, behavioral coaching, and individualized prevention, offering scalability and low-intensity interventions. However, AI also raises ethical and regulatory concerns, especially for patient-facing tools. Limited evidence compares public comfort with physician use versus patient use for diabetes prevention.
Methods
We analyzed data from a 2025 national survey conducted through the NORC AmeriSpeak Panel, a probability-based sample of 1,939 respondents. Participants evaluated two hypothetical AI use cases for diabetes prevention: Physician use of AI and patient use of AI-chatbot. Paired t-tests compared comfort across use cases. Weighted univariable and multivariable logistic regression models identified predictors of comfort.
Results
Participants reported significantly greater comfort with physician use of AI than with patient use of an AI-chatbot for diabetes prevention ( p < 0.001). Comfort across both cases was strongly associated with belief that AI benefits population health (patient-AI: OR = 3.67, p < 0.001; physician-AI: OR = 3.86, p < 0.001), trust in health system AI use (patient-AI: OR = 1.47, p < 0.001, physician-AI: OR = 1.72, p < 0.001), and physician confidence in AI reliability (patient-AI: OR = 1.31, P = 0.003; physician-AI: OR = 1.30, p < 0.001). Comfort with physician use of AI was lower among Black/African American participants than White participants (OR = 0.51, p < 0.001), while women reported lower comfort with patient use of AI compared than men (OR = 0.71, p = 0.032)
Conclusions
Public comfort with AI for diabetes prevention appears higher when integrated with professional oversight. Trust in clinicians, health systems, and AI reliability may be central to acceptance. Differences across demographic groups highlight the importance of equity-focused, physician-led implementation, transparent communication, and inclusive trust-building strategies for ethical AI adoption.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- TIERRA - Trust, Innovation & Ethics Research for Responsible AI, Department of Learning Health Science, Michigan Medicine, University of Michigan, Ann Arbor, MI, United States.
- Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN, United States.
Förderung
- NIBIB NIH HHS
Zitieren
APA
Carmona Clavijo, G. M., Nong, P., Tan, S., & Platt, J. (2026). Physician versus patient use of AI for diabetes prevention: public perceptions and comfort levels. Frontiers in Digital Health, 8. https://doi.org/10.3389/fdgth.2026.1879415
Vancouver
Carmona Clavijo GM, Nong P, Tan S, Platt J. Physician versus patient use of AI for diabetes prevention: public perceptions and comfort levels. Frontiers in Digital Health. 2026;8. doi:10.3389/fdgth.2026.1879415
BibTeX
@article{CarmonaClavijo2026,
author = {Carmona Clavijo, Gloria Maria and Nong, Paige and Tan, Sean and Platt, Jodyn},
title = {Physician versus patient use of AI for diabetes prevention: public perceptions and comfort levels},
journal = {Frontiers in Digital Health},
year = {2026},
volume = {8},
doi = {10.3389/fdgth.2026.1879415}
}
EUVIMED